Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

• Status: Active, not recruiting
• Trial end date: 2021-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Heat-sensitive moxibustion is considered to be effective for primary hypertension in hospital setting. This study aims to investigate whether heat-sensitive moxibustion self-administration is effective for lowering blood pressure and improving quality of life for patients with primary hypertension in community setting using a multicenter, prospective, non-randomized study design

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jiangxi University of Traditional Chinese Medicine
• Collaborators: Gaofu town community healthcare center (Fu Zhou city, Jiangxi province, China); Honggutan community healthcare center (Nanchang city, Jiangxi province, China); Nangang community healthcare center (Nanchang city, Jiangxi province, China); Shengmi community healthcare center (Nanchang city, Jiangxi province, China)
• Treatments: Antihypertensive Agents

Criteria

Inclusion Criteria:

1. Meet the diagnostic criteria of primary hypertension

2. 18 to 70 years old

3. Sign the informed consent

Exclusion Criteria:

1. Secondary hypertension caused by kidney disease, macrovascular disease, pregnancy, endocrine disease, brain disease, drug-induced factors, etc.

2. Allergic to moxibustion equipment, moxa smoke or moxa

3. Pregnancy or lactation

4. A history of serious cardiovascular and cerebrovascular events such as cerebrovascular accidents and myocardial infarction

5. Complicated by liver and kidney dysfunction indicated by total bilirubin, alanine aminotransferase, aspartate aminotransferase, or blood creatinine are more than 2 times upper limit of normal value

6. Complicated by malignant tumors

7. Complicated by major mental disorders